×
GlucoTrack Total Liabilities 2011-2024 | GCTK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GlucoTrack total liabilities from 2011 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Quarterly Chart
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$229.2B
Boston Scientific (BSX)
$155.9B
Stryker (SYK)
$148.3B
EssilorLuxottica (ESLOY)
$140.1B
Medtronic (MDT)
$111.6B
Lonza Group Ag (LZAGY)
$46.2B
Haleon (HLN)
$45.2B
GE HealthCare Technologies (GEHC)
$42.3B
Agilent Technologies (A)
$39.1B
ResMed (RMD)
$34.4B
Terumo (TRUMY)
$26.6B
Koninklijke Philips (PHG)
$23.5B
Zimmer Biomet Holdings (ZBH)
$20.6B
Insulet (PODD)
$19.9B
Baxter (BAX)
$15.7B
Sunny Optical Technology (SNPTF)
$11.3B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.9B
Demant (WILYY)
$7.9B
Bio-Rad Laboratories (BIO)
$7.9B
Lantheus Holdings (LNTH)
$5.7B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.4B
Haemonetics (HAE)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.8B
LeMaitre Vascular (LMAT)
$2.3B